BANK OF AMERICA CORP /DE/ - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVB and the CUSIP is 63937X202. A total of 27 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2023$143
-3.4%
1,6040.0%0.00%
Q2 2023$148
-51.8%
1,604
+36.0%
0.00%
Q1 2023$307
+23.8%
1,1790.0%0.00%
Q4 2022$2481,179
-31.5%
0.00%
Q3 2022$0
-100.0%
1,7220.0%0.00%
Q2 2022$1,0000.0%1,7220.0%0.00%
Q1 2022$1,000
-50.0%
1,722
-10.1%
0.00%
Q4 2021$2,000
-33.3%
1,915
+5.1%
0.00%
Q3 2021$3,0000.0%1,822
-0.4%
0.00%
Q2 2021$3,0000.0%1,829
+0.4%
0.00%
Q1 2021$3,000
-40.0%
1,822
-25.5%
0.00%
Q4 2020$5,000
-16.7%
2,447
-6.7%
0.00%
Q3 2020$6,000
-57.1%
2,622
-30.5%
0.00%
Q2 2020$14,000
+600.0%
3,775
+60.8%
0.00%
Q1 2020$2,000
-33.3%
2,3470.0%0.00%
Q4 2019$3,000
+50.0%
2,347
-19.8%
0.00%
Q3 2019$2,000
+100.0%
2,928
+130.2%
0.00%
Q2 2019$1,0001,2720.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q2 2022
NameSharesValueWeighting ↓
Allred Capital Management, LLC 52,926$113,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,940$236,0000.01%
PATHSTONE FAMILY OFFICE, LLC 10,050$22,0000.00%
Sowell Financial Services LLC 11,190$24,0000.00%
TWO SIGMA INVESTMENTS, LP 101,949$219,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 32,822$71,0000.00%
UBS Group AG 816$2,0000.00%
IFP Advisors, Inc 50$00.00%
OSAIC HOLDINGS, INC. 6$00.00%
Jacobi Capital Management LLC 1,000$2,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders